GRANULOCYTE COLONY-STIMULATING FACTOR NOS for Bone marrow conditioning regimen: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 49 adverse event reports in the FDA FAERS database where GRANULOCYTE COLONY-STIMULATING FACTOR NOS was used for Bone marrow conditioning regimen.
Most Reported Side Effects for GRANULOCYTE COLONY-STIMULATING FACTOR NOS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 350 | 15.9% | 65 | 81 |
| Product use in unapproved indication | 192 | 8.7% | 51 | 32 |
| Haematotoxicity | 186 | 8.5% | 20 | 0 |
| Off label use | 169 | 7.7% | 59 | 50 |
| Death | 167 | 7.6% | 167 | 7 |
| Neutropenia | 157 | 7.1% | 27 | 33 |
| Sepsis | 134 | 6.1% | 71 | 53 |
| Thrombocytopenia | 134 | 6.1% | 29 | 17 |
| Pyrexia | 125 | 5.7% | 23 | 51 |
| Disease progression | 119 | 5.4% | 73 | 9 |
| Mucosal inflammation | 100 | 4.6% | 39 | 28 |
| Diarrhoea | 94 | 4.3% | 22 | 18 |
| Pneumonia | 87 | 4.0% | 29 | 35 |
| Drug ineffective | 81 | 3.7% | 30 | 21 |
| Anaemia | 79 | 3.6% | 11 | 16 |
Other Indications for GRANULOCYTE COLONY-STIMULATING FACTOR NOS
Acute myeloid leukaemia (344)
Product used for unknown indication (249)
Prophylaxis (198)
Neutropenia (117)
Acute lymphocytic leukaemia (102)
Peripheral blood stem cell apheresis (66)
Stem cell therapy (62)
Diffuse large b-cell lymphoma (54)
Haematopoietic stem cell mobilisation (51)
B-cell lymphoma (40)
Other Drugs Used for Bone marrow conditioning regimen
FLUDARABINE (6,080)
BUSULFAN (4,669)
CYCLOPHOSPHAMIDE (4,485)
MELPHALAN (2,368)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884)
THIOTEPA (1,551)
ALEMTUZUMAB (1,122)
ETOPOSIDE (936)
CYTARABINE (833)
THYMOCYTE IMMUNE GLOBULIN NOS (742)